First Header Logo Second Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Carolanne Milligan and James Caress.
Connection Strength

1.208
  1. Wosiski-Kuhn M, Caress JB, Cartwright MS, Hawkins GA, Milligan C. Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2021 05; 22(3-4):248-259.
    View in: PubMed
    Score: 0.187
  2. Wosiski-Kuhn M, Robinson M, Strupe J, Arounleut P, Martin M, Caress J, Cartwright M, Bowser R, Cudkowicz M, Langefeld C, Hawkins GA, Milligan C. IL6 receptor358Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm. 2019 11; 6(6):e631.
    View in: PubMed
    Score: 0.176
  3. Lyon MS, Wosiski-Kuhn M, Gillespie R, Caress J, Milligan C. Inflammation, Immunity, and amyotrophic lateral sclerosis: I. Etiology and pathology. Muscle Nerve. 2019 01; 59(1):10-22.
    View in: PubMed
    Score: 0.164
  4. Wosiski-Kuhn M, Lyon MS, Caress J, Milligan C. Inflammation, immunity, and amyotrophic lateral sclerosis: II. immune-modulating therapies. Muscle Nerve. 2019 01; 59(1):23-33.
    View in: PubMed
    Score: 0.164
  5. Vinsant S, Mansfield C, Jimenez-Moreno R, Del Gaizo Moore V, Yoshikawa M, Hampton TG, Prevette D, Caress J, Oppenheim RW, Milligan C. Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part I, background and methods. Brain Behav. 2013 Jul; 3(4):335-50.
    View in: PubMed
    Score: 0.113
  6. Vinsant S, Mansfield C, Jimenez-Moreno R, Del Gaizo Moore V, Yoshikawa M, Hampton TG, Prevette D, Caress J, Oppenheim RW, Milligan C. Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: part II, results and discussion. Brain Behav. 2013 Jul; 3(4):431-57.
    View in: PubMed
    Score: 0.113
  7. Gifondorwa DJ, Jimenz-Moreno R, Hayes CD, Rouhani H, Robinson MB, Strupe JL, Caress J, Milligan C. Administration of Recombinant Heat Shock Protein 70 Delays Peripheral Muscle Denervation in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis. Neurol Res Int. 2012; 2012:170426.
    View in: PubMed
    Score: 0.107
  8. Gifondorwa DJ, Robinson MB, Hayes CD, Taylor AR, Prevette DM, Oppenheim RW, Caress J, Milligan CE. Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J Neurosci. 2007 Nov 28; 27(48):13173-80.
    View in: PubMed
    Score: 0.077
  9. Qadri S, Langefeld CD, Milligan C, Caress JB, Cartwright MS. Racial differences in intervention rates in individuals with ALS: A case-control study. Neurology. 2019 04 23; 92(17):e1969-e1974.
    View in: PubMed
    Score: 0.042
  10. Pathak S, Caress JB, Wosiski-Kuhn M, Milligan C, Williams D, Cartwright MS. A pilot study of neuromuscular ultrasound as a biomarker for amyotrophic lateral sclerosis. Muscle Nerve. 2019 02; 59(2):181-186.
    View in: PubMed
    Score: 0.041
  11. Hernández S, Texidó L, Calderó J, Ciutat D, Piedrafita L, Casanovas A, Blasi J, Solsona C, Povedano M, Rojas R, Illa I, Caress J, Prevette D, Oppenheim RW, Milligan C, Esquerda JE. Increased intramuscular nerve branching and inhibition of programmed cell death of chick embryo motoneurons by immunoglobulins from patients with motoneuron disease. J Neuroimmunol. 2010 Dec 15; 229(1-2):157-68.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.